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Low-density lipoprotein (LDL) size is heterogeneous in
humans and different subtypes of LDL are defined. Among
LDL subclasses, two different fractions have been isolated,
namely, larger (pattern A) and smaller, more dense particles
(pattern B) (1,2). Genetic and environmental factors may
affect LDL particle size (1-6). The prevalence of pattern B
phenotype is 5-10% in women and men younger than 20
years and 30% in older men (1,2). Generally, expression of
the small dense LDL (sd-LDL) phenotype appears in 
adulthood as a result of genetic, as well as environmental
factors. Obesity, dyslipidemia and insulin resistance are
accepted as important environmental factors leading to the
development of pattern B (6,7,9-11).
Frequency of obesity and obesity-related diseases has
increased both in adults and children. Obese individuals
carry risks of cardiovascular diseases (CVD) (12). Some risk
factors may be present at a young age, and in these patients
the lifelong approach for prevention of CVD must be 
initiated  (13,14). In recent years, it has been shown that
small LDL particle size is associated with atherosclerotic
coronary artery disease (15,16). LDL particle size measurement
is proposed in adult patients who have a high risk of 
coronary artery disease (8).
In this study, we aimed to investigate the effects of
insulin resistance and obesity on LDL particle size in children
and to assess the need for routine measurement of LDL 
particle size in obese children for the prediction of CVD.
ABSTRACT
Objective: In adults, it was shown that obesity and insulin resistance
affect low-density lipoprotein (LDL) particle size and small dense (sd)
LDL is associated with cardiovascular diseases. In this study, we 
investigated the effect of obesity and insulin resistance on LDL particle
size. 
Methods: Twenty-six obese children (13 girls, 13 boys) with a median
age of 10.5 years and 27 healthy control subjects (17 girls, 10 boys) with
a median age of 11.5 were enrolled in the study. 
Results: The number of patients with insulin resistance in the obese
group was 15 out of 26. In the control group, there was no subject with
insulin resistance. Serum triglyceride and very LDL (VLDL) levels were
higher and serum high-density lipoprotein levels (HDL) were lower in the
obese patients than in the controls. There was no statistical difference
in the LDL particle size between the two groups (medians: 26.6 vs. 26.7
nm (p=0.575)). The size of LDL particle was not correlated with body
mass index (BMI) standard deviation score (SDS), homeostasis model
assessment of insulin resistance (HOMA-IR), or serum lipids.
Conclusion: Measurement of LDL particle size as a routine procedure
is not necessary in childhood obesity. 
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Twenty-six obese children (13 girls, 13 boys) with a
median age of 10.5 and 27 healthy control subjects 
(17 girls, 10 boys) with a median age of 11.5 were enrolled
in the study. 
Body mass index (BMI) was calculated as weight in 
kilograms divided by height in square meters. Subjects who
had a BMI above the 95th percentile for age and sex or a
BMI standard deviation score (SDS) above +2.0 SD were
classified as obese (17). Homeostasis model assessment
of insulin resistance (HOMA-IR) index (fasting insulin x fasting
glucose/22.5) was used for determining insulin resistance
(18). Insulin resistance criteria were HOMA-IR>2.5 for 
prepubertal children and HOMA-IR>4.0 for adolescents (19).
Children with obesity due to syndromes or other known
causes were not taken into the study. Control subjects
were healthy children. Sixteen patients in the obese group
and 15 children in the control group were pubertal.
All blood samples were taken in the morning between
08.00 and 09.00 hours after an over-night fast. The levels of
serum insulin, glucose, total cholesterol, triglyceride, 
high-density lipoprotein (HDL), very low-density lipoprotein
(VLDL) and LDL were measured and the serum samples
were stored at -80ºC for measuring LDL particle size. 
We used polyacrylamide gradient gel electrophoresis to
eliminate the interference of fatty acids and devised a 
simple, precise method of polyacrylamide gradient gel 
electrophoresis to measure the diameter of sd-LDL in
serum. We used apoferritin and thyroglobulin, which have a
molecular diameter of 12.2 nm and 17.0 nm, respectively,
and standard LDL particles having a diameter of 25.7 and
27.0 nm as calibrators, estimated by measurement of 
negative staining of electron microscopy. We also included
apoferritin as an internal standard for polyacrylamide 
gradient gel electrophoresis. The only stain used was
Coomassie brilliant blue, and it was used for lipoprotein
staining. When we used LDL of 25.73 nm in diameter as a
quality control specimen, the coefficient of variation of the
size measurements obtained by our method was less 
than 1.2%.
Informed parent consent was taken for each child and
this study was approved by the local ethics committee.
Statistics
All statistics were performed using the program SPSS
15.0 for Windows. Mann-Whitney U test was used for 
comparisons of two groups. Spearman’s correlations were
used for calculating correlations between parameters.
Results
The number of patients with insulin resistance in the
obese group was 15 out of 26. In the control group, there
was no subject with insulin resistance. The value of 
HOMA-IR was higher in obese patients than in the controls
(p<0.001). Serum triglyceride and VLDL levels were higher
and serum HDL level was lower in obese patients than in
controls (p<0.05). There was no statistical difference in the
LDL particle size between the two groups. Clinical and 
laboratory features of the groups are shown in Table 1. 
Serum triglycerides and VLDL were positively, and HDL
was negatively correlated with HOMA-IR (Table 2), while
LDL particle size was not correlated with any of these 
values. The size of LDL particles was not correlated with
BMI SDS or HOMA-IR. Four subjects, two in obese group
and two in the control group, had sd-LDL.
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Table 1. Clinical and laboratory features of the groups (median values and ranges)
Obese (n=26) group Control (n=27) group p
Age (years) 10.5 (5.4-15.3) 11.5 (5-15.3) 0.796
Sex (girls/boys) (ratio) 13/13 17/10 0.250
BMI SDS  2.3 (2.1-2.4) 0.1 (-1.1-1.6) <0.001
HOMA-IR 3.3 (0.9-8.3) 1.8 (0.5-3.1) <0.001
Prepubertal 2.2 (0.9-7.8) 1.7 (0.5-2.2) <0.001
Pubertal  3.9 (1.3-8.3) 1.9 (0.4-2.3) <0.001
HDL (mg/dl) 46 (30-76) 55 (24-82) 0.004
LDL (mg/dl) 106 (61-210) 93 (53-147) 0.051
VLDL (mg/dl) 21 (6-110) 16 (9-41) 0.030
Total cholesterol (mg/dl) 179 (134-295) 163 (132-216) 0.206
Triglycerides (mg/dl) 107 (32-444) 82 (44-237) 0.031
LDL particle size (nm) 26.6 (25.3-27.6) 26.7 (25.1-28.1) 0.575
BMI SDS: body mass index standard deviation score; HOMA-IR: Homeostatic assessment of insulin resistance; HDL: high density lipoprotein; LDL: low density lipoprotein;
VLDL: very low density lipoproteinDiscussion
In this study, we investigated LDL particle size in obese
children and its relationship with insulin resistance and 
serum lipid levels. Obesity, the expanding problem of the
world, precipitates cardiovascular diseases. Autopsy 
studies have demonstrated that atherosclerotic process 
begins in childhood (20,21). Some risk factors for ischemic
heart diseases in the obese population are dyslipidemia,
hypertension and insulin resistance (22). In recent years,
small LDL particle size has been suggested to be one of the
risk factors. Different mechanisms have been proposed for
atherogenicity of sd-LDL (23,24). Björnheden at al (24) have
reported that sd-LDL may be taken up easily by arterial 
tissue because of greater transendothelial transport of
smaller particles (24). 
It has been reported that the prevalence of sd-LDL was
9.3% in children (25) and 44% in adults (26). Miyashita et al (27)
reported that 40% of obese children have sd-LDL. In our
study, the prevalence of sd-LDL in the obese group was not
as high as that reported by Miyashita’s group. Different 
factors may play a role in the explanation of our results.
Firstly, the genetic make-up of the Turkish population may
be different. Genetic factors are important. Previously, the
inheritance of sd-LDL was reported as autosomal dominant
(28). It has been reported that dominant inheritance has an
age-dependent penetration. Our group of subjects was also
younger than Miyashita’s group. Shea et al (29) have 
demonstrated that plasma insulin may modulate lipid levels
and particle size in very young children. Rainwanter et al (30)
have reported that young men and women had a lower 
prevalence of small LDL than men and women of an older age.
In adults, it has been demonstrated that serum 
triglyceride levels are major determinants of LDL particle 
size (31). In case of hypertriglyceridemia, VLDL transfers its
triglycerides to HDL. Triglycerides of this HDL are transferred
to the LDL and the cholesterol of LDL is removed from the
molecule. This form of LDL with high triglyceride and low
cholesterol becomes smaller and denser (32,33). Obesity is
another factor that influences LDL particle size (34). 
Yoshino et al (35) have reported that LDL particle size 
increases with weight reduction, although serum lipids do
not change significantly.
In our study group, we did not find any relationship 
between obesity and LDL particle size. Dyslipidemia 
existed in our children, nevertheless, it did not have any 
correlation with the pathological clinical and laboratory 
findings. Although obese children had higher triglycerides
and lower HDL than controls, LDL particle size did not have
any correlation with these laboratory findings and obesity.
In conclusion, according to our results, it is not 
necessary to evaluate routinely LDL particle size in obese
children. Additional studies with a large number of subjects
are needed to evaluate more definitely LDL particle size 
status, especially in children. 
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